Planimeter was founded in 1997 to provide data management and statistical support for the pharmaceutical industry with a focus on the analysis of data from clinical trials and postmarketing surveys.
As for therapeutic areas we have the most experiences in oncology, respiratory diseases, neurology, cardiovascular diseases, diabetes and nephrology. This includes working on a range of specific measures, outcomes and endpoints: e.g. various blood pressure assessments (including ambulatory), a wide variety of questionnaires and a broad spectrum of laboratory datasets (including histochemistry).
Whilst we provide a full data management and statistical service for clinical trials from design to reporting, Planimeter has extensive experience in support of post-marketing or observational studies.
- Verified data entry (using automatic pre-defined checks)
- AE / SAE reporting
- Payment management
- Fraud detection
- Status reporting
- Automated reporting
- Multilingual environment
Our EDC systems are running in seven countries, and many further projects are under discussion.
Deployment and continuous improvement of our EDC-based approach led us to develop Patient Registries.
Three of our Patient Registries have been implemented recently and further registries are in the pipeline.
Planimeter has also gained a reputation as a pharmacovigilance (PV) service provider. Our main focus is monitoring of the Hungarian Medical Literature for possible adverse events (AEs). We play an important role in this segment and this fact led to further projects in this area like Facebook or web-page content monitoring.